» Articles » PMID: 32032477

Point-of-care Oral Cytology Tool for the Screening and Assessment of Potentially Malignant Oral Lesions

Abstract

Background: The effective detection and monitoring of potentially malignant oral lesions (PMOL) are critical to identifying early-stage cancer and improving outcomes. In the current study, the authors described cytopathology tools, including machine learning algorithms, clinical algorithms, and test reports developed to assist pathologists and clinicians with PMOL evaluation.

Methods: Data were acquired from a multisite clinical validation study of 999 subjects with PMOLs and oral squamous cell carcinoma (OSCC) using a cytology-on-a-chip approach. A machine learning model was trained to recognize and quantify the distributions of 4 cell phenotypes. A least absolute shrinkage and selection operator (lasso) logistic regression model was trained to distinguish PMOLs and cancer across a spectrum of histopathologic diagnoses ranging from benign, to increasing grades of oral epithelial dysplasia (OED), to OSCC using demographics, lesion characteristics, and cell phenotypes. Cytopathology software was developed to assist pathologists in reviewing brush cytology test results, including high-content cell analyses, data visualization tools, and results reporting.

Results: Cell phenotypes were determined accurately through an automated cytological assay and machine learning approach (99.3% accuracy). Significant differences in cell phenotype distributions across diagnostic categories were found in 3 phenotypes (type 1 ["mature squamous"], type 2 ["small round"], and type 3 ["leukocytes"]). The clinical algorithms resulted in acceptable performance characteristics (area under the curve of 0.81 for benign vs mild dysplasia and 0.95 for benign vs malignancy).

Conclusions: These new cytopathology tools represent a practical solution for rapid PMOL assessment, with the potential to facilitate screening and longitudinal monitoring in primary, secondary, and tertiary clinical care settings.

Citing Articles

Factors influencing engagement in oral cancer prevention activities among dental students and professionals in Saudi Arabia.

Shubayr M, Al Moaleem M, Hakami S, Khalufi K, Daghriri R, Bokhari A BMC Oral Health. 2024; 24(1):1465.

PMID: 39633404 PMC: 11619440. DOI: 10.1186/s12903-024-05266-7.


Embracing technological revolution: A panorama of machine learning in dentistry.

Lin H, Chen J, Hu Y, Li W Med Oral Patol Oral Cir Bucal. 2024; 29(6):e742-e749.

PMID: 39418127 PMC: 11584966. DOI: 10.4317/medoral.26679.


Beta-defensin index: A functional biomarker for oral cancer detection.

Ghosh S, Man Y, Fraiwan A, Waters C, McKenzie C, Lu C Cell Rep Med. 2024; 5(3):101447.

PMID: 38442713 PMC: 10983043. DOI: 10.1016/j.xcrm.2024.101447.


CD44-SNA1 integrated cytopathology for delineation of high grade dysplastic and neoplastic oral lesions.

Sunny S, D R R, Hariharan A, Mukhia N, Gurudath S, G K PLoS One. 2023; 18(9):e0291972.

PMID: 37747904 PMC: 10519609. DOI: 10.1371/journal.pone.0291972.


Simultaneous Quantitative SARS-CoV-2 Antigen and Host Antibody Detection and Pre-Screening Strategy at the Point of Care.

Srinivasan Rajsri K, McRae M, Christodoulides N, Dapkins I, Simmons G, Matz H Bioengineering (Basel). 2023; 10(6).

PMID: 37370601 PMC: 10295356. DOI: 10.3390/bioengineering10060670.


References
1.
Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E . Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008; 37(3):127-33. DOI: 10.1111/j.1600-0714.2007.00584.x. View

2.
McDevitt J, Weigum S, Floriano P, Christodoulides N, Redding S, Yeh C . A new bio-nanochip sensor aids oral cancer detection. SPIE Newsroom. 2011; . PMC: 3148937. DOI: 10.1117/2.1201102.003547. View

3.
Vigneswaran N, Beckers S, Waigel S, Mensah J, Wu J, Mo J . Increased EMMPRIN (CD 147) expression during oral carcinogenesis. Exp Mol Pathol. 2005; 80(2):147-59. DOI: 10.1016/j.yexmp.2005.09.011. View

4.
Speight P, Abram T, Floriano P, James R, Vick J, Thornhill M . Interobserver agreement in dysplasia grading: toward an enhanced gold standard for clinical pathology trials. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120(4):474-82.e2. PMC: 4564355. DOI: 10.1016/j.oooo.2015.05.023. View

5.
Brands M, Smeekens E, Takes R, Kaanders J, Verbeek A, Merkx M . Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer. Cancer Med. 2019; 8(12):5810-5819. PMC: 6745868. DOI: 10.1002/cam4.2124. View